These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7834965)

  • 1. Polymer conjugates. Pharmacokinetic considerations for design and development.
    Duncan R; Spreafico F
    Clin Pharmacokinet; 1994 Oct; 27(4):290-306. PubMed ID: 7834965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer conjugates: nanosized medicines for treating cancer.
    Vicent MJ; Duncan R
    Trends Biotechnol; 2006 Jan; 24(1):39-47. PubMed ID: 16307811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG conjugates in clinical development or use as anticancer agents: an overview.
    Pasut G; Veronese FM
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1177-88. PubMed ID: 19671438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer-drug conjugates: present state of play and future perspectives.
    Pang X; Du HL; Zhang HQ; Zhai YJ; Zhai GX
    Drug Discov Today; 2013 Dec; 18(23-24):1316-22. PubMed ID: 24055841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer therapeutics: concepts and applications.
    Haag R; Kratz F
    Angew Chem Int Ed Engl; 2006 Feb; 45(8):1198-215. PubMed ID: 16444775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profile.
    Siddalingappa B; Benson HA; Brown DH; Batty KT; Chen Y
    PLoS One; 2015; 10(3):e0118824. PubMed ID: 25799413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradable Polyphosphoester-Protein Conjugates: "PPEylation" of Proteins.
    Steinbach T; Wurm FR
    Biomacromolecules; 2016 Oct; 17(10):3338-3346. PubMed ID: 27618845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-drug conjugate therapeutics: advances, insights and prospects.
    Ekladious I; Colson YL; Grinstaff MW
    Nat Rev Drug Discov; 2019 Apr; 18(4):273-294. PubMed ID: 30542076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and development of polymer conjugates as anti-angiogenic agents.
    Segal E; Satchi-Fainaro R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1159-76. PubMed ID: 19699248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of proteins from their poly(ethylene glycol) conjugates: drug delivery systems employing 1,6-elimination.
    Greenwald RB; Yang K; Zhao H; Conover CD; Lee S; Filpula D
    Bioconjug Chem; 2003; 14(2):395-403. PubMed ID: 12643750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
    Duncan R; Vicent MJ; Greco F; Nicholson RI
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S189-99. PubMed ID: 16113096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-Polymer Conjugates Synthesized Using Water-Soluble Azlactone-Functionalized Polymers Enable Receptor-Specific Cellular Uptake toward Targeted Drug Delivery.
    Kim JS; Sirois AR; Vazquez Cegla AJ; Jumai'an E; Murata N; Buck ME; Moore SJ
    Bioconjug Chem; 2019 Apr; 30(4):1220-1231. PubMed ID: 30920802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic protein-polymer conjugates: advancing beyond PEGylation.
    Pelegri-O'Day EM; Lin EW; Maynard HD
    J Am Chem Soc; 2014 Oct; 136(41):14323-32. PubMed ID: 25216406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-polymer conjugation-moving beyond PEGylation.
    Qi Y; Chilkoti A
    Curr Opin Chem Biol; 2015 Oct; 28():181-93. PubMed ID: 26356631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Bio Distribution.
    Dyawanapelly S; Junnuthula VR; Singh A
    Curr Drug Metab; 2015; 16(7):522-37. PubMed ID: 25523548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-drug conjugates: current status and future trends.
    Greco F; Vicent MJ
    Front Biosci; 2008 Jan; 13():2744-56. PubMed ID: 17981750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart branched polymer drug conjugates as nano-sized drug delivery systems.
    Duro-Castano A; Movellan J; Vicent MJ
    Biomater Sci; 2015 Oct; 3(10):1321-34. PubMed ID: 26266272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.